Skip to main content
New laboratory accounts: 10% off your first order with code

GLP-2 research

GLP-2 & Teduglutide: Gut-Health Research Peptide Guide

Glucagon-like peptide-2 (GLP-2) is the lesser-known sibling of GLP1. Where GLP1 research centres on glycaemic and appetite pathways, GLP-2 research centres on the intestinal epithelium — crypt cell proliferation, villus height and barrier integrity. Teduglutide is the best-characterised GLP-2 analogue in the literature. This guide explains the biology, the evidence base, how GLP-2 differs from GLP1, and the handling and documentation standards to apply when sourcing reference material for laboratory work.

Reading this research reference

The information below concerns the research subject, not proof of the identity or performance of a supplied material. Check the original sources and your laboratory’s requirements; product documentation must be assessed separately for the exact batch.

What GLP-2 is

GLP-2 is a 33-amino-acid peptide cleaved from proglucagon in enteroendocrine L-cells of the distal small intestine and colon — the same precursor that yields GLP1. It is released after nutrient intake and acts on the GLP-2 receptor, a class B G-protein-coupled receptor expressed on subepithelial myofibroblasts, enteric neurons and enteroendocrine cells rather than on enterocytes directly. Signalling is therefore indirect, mediated through IGF-1, ErbB ligands and nitric-oxide pathways.

Why teduglutide exists

Native GLP-2 is degraded within minutes by dipeptidyl peptidase-4 (DPP-4), which cleaves the N-terminal dipeptide. Teduglutide substitutes alanine at position 2 with glycine ([Gly2]GLP-2), which resists DPP-4 cleavage and extends the circulating half-life from roughly 7 minutes to several hours. That single substitution is what makes the molecule usable as an experimental reference standard rather than a laboratory curiosity.

GLP-2 vs GLP1 — the practical difference

Both peptides come from proglucagon and both are released after eating, but their receptors and downstream literature diverge almost completely. GLP1 and GLP-2 research focus on different pathways and are not interchangeable.

In practical terms, a researcher comparing GLP1 and GLP-2 material is comparing metabolic endpoints against gastrointestinal-barrier endpoints. The two are not interchangeable, and protocols written for one do not transfer to the other.

What the literature reports

Teduglutide is the most-studied GLP-2 analogue, with published clinical work in short bowel syndrome showing increased intestinal absorptive capacity and reduced parenteral support requirements. Preclinical models report increased villus height, deeper crypts and improved barrier function after GLP-2 receptor agonism.

Beyond that indication, GLP-2 appears in exploratory literature on intestinal barrier permeability, chemotherapy-induced mucositis models and inflammatory bowel disease models. Those datasets are preclinical or early-phase; they describe mechanism, not established outcomes. Anyone reading GLP-2 material should keep the distinction between an approved indication and an exploratory model firmly in view.

Handling, reconstitution and storage

Treat GLP-2 analogue reference material like any lyophilised research peptide: keep sealed vials at 2–8 °C and out of light, reconstitute with bacteriostatic water added down the inner wall of the vial, swirl rather than shake, and label with date, concentration and lot number. Sealed 10-vial kits held in cold storage stay stable for roughly 8–12 months; once reconstituted, expect around 2 months of refrigerated in-use stability at 2–8 °C. The lot-matched COA always overrides a general rule of thumb.

What to check on the COA

Confirm four things before accepting a batch: HPLC purity with the chromatogram attached (not just a stated percentage), mass-spectrometry identity confirmation matching the expected molecular weight for the [Gly2]GLP-2 sequence, peptide content by nitrogen or amino-acid analysis so you know the actual peptide mass in the vial, and a lot number that matches the vial label. Bio Mech publishes independent third-party reports in the COA library so the batch you receive is the batch you can read about.

Sourcing and study design notes

Plan vial count against study length before ordering — Bio Mech supplies research peptides in 10-vial kits of a single compound, which typically covers an 8–12 month research cycle. If you are unsure which reference compounds fit a gut-barrier protocol, the catalogue and a short consultation are the fastest route.

Frequently asked questions

What is GLP-2?+

GLP-2 is a 33-amino-acid peptide cleaved from proglucagon in intestinal L-cells. It acts on the GLP-2 receptor to drive intestinal crypt cell proliferation, villus growth and barrier integrity, rather than the glycaemic and appetite pathways associated with GLP1.

What is teduglutide?+

Teduglutide is a DPP-4-resistant GLP-2 analogue ([Gly2]GLP-2) in which alanine at position 2 is replaced by glycine. That substitution extends the half-life from around 7 minutes to several hours, making it the best-characterised GLP-2 reference compound in the literature.

How is GLP-2 different from GLP1?+

They share the proglucagon precursor but act on different receptors and different tissues. GLP1 research focuses on insulin secretion, gastric emptying and appetite; GLP-2 research focuses on intestinal mucosal growth and barrier function. Protocols are not interchangeable.

What does GLP-2 research look at?+

Published and preclinical GLP-2 literature examines villus height, crypt depth, enterocyte apoptosis, mesenteric blood flow, tight-junction expression and intestinal absorptive capacity — including clinical work in short bowel syndrome and preclinical models of mucositis and intestinal inflammation.

How should GLP-2 peptide vials be stored?+

Keep sealed lyophilised vials at 2–8 °C away from light — sealed 10-vial kits stay stable for roughly 8–12 months. After reconstitution with bacteriostatic water, expect around 2 months of refrigerated in-use stability, and always follow the lot-matched COA.

Is teduglutide a GLP1 agonist?+

No. Teduglutide is a GLP-2 receptor agonist and is not interchangeable with GLP1 research compounds.

Share

Continue your research

Order in 3 steps · tracked delivery

Order research peptides for your laboratory

Published laboratory reports can be opened in the COA library; confirm the compound and production lot for your order. Dispatch is tracked; normally allow 5–11 business days from when we issue tracking (Brazil up to 25; Kuwait up to 14). For in-vitro research only.

  1. 1

    Choose your compound

    Browse the catalog or search for a specific reference standard.

  2. 2

    Checkout in 2 minutes

    Bank transfer or card — the full price is shown before you pay.

  3. 3

    Tracked dispatch

    Tracking on every order; 5–11 business days from issuing tracking; Brazil up to 25, Kuwait up to 14.

Most ordered this month

BPC-157

From €319.00

Ipamorelin

From €299.00

Bacteriostatic Water

From €179.00

  • Research use only — not for human consumption
  • Tracked delivery to the USA, UK, Europe and the Middle East
  • Batch documentation available on request

Your research order

From research to the right specification.

Compare listed sizes and prices, make your own selection, then review your order before paying. Laboratory research only; not for human consumption.

Choose your own items
Nothing added automatically

Card or bank transfer
Total shown before payment

Tracked delivery
5–11 working days from active tracking